Differential Effects of MYH9 and APOL1 Risk Variants on FRMD3 Association with Diabetic ESRD in African Americans-Reference-Cited by-同舟云学术

Differential Effects of MYH9 and APOL1 Risk Variants on FRMD3 Association with Diabetic ESRD in African Americans

Published:2011-06-16 Issue:6 Volume:7 Page:e1002150
ISSN:1553-7404
Container-title:PLoS Genetics
language:en
Short-container-title:PLoS Genet

Author:

Freedman Barry I.,Langefeld Carl D.,Lu Lingyi,Divers Jasmin,Comeau Mary E.,Kopp Jeffrey B.,Winkler Cheryl A.,Nelson George W.,Johnson Randall C.,Palmer Nicholette D.,Hicks Pamela J.,Bostrom Meredith A.,Cooke Jessica N.,McDonough Caitrin W.,Bowden Donald W.

Publisher

Public Library of Science (PLoS)

Subject

Cancer Research,Genetics (clinical),Genetics,Molecular Biology,Ecology, Evolution, Behavior and Systematics

Reference28 articles.

1. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.;JB Kopp;Nat Genet,2008

2. MYH9 is associated with nondiabetic end-stage renal disease in African Americans.;WH Kao;Nat Genet,2008

3. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.;BI Freedman;Kidney Int,2009

4. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.;BI Freedman;Nephrol Dial Transplant,2009

5. Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study.;BI Freedman;Am J Nephrol,2009

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular biology, genetic, and epigenetics of kidney disease;Genetics and Epigenetics of Genitourinary Diseases;2025

2. “Predicting diabetic kidney disease in youth with type 1 diabetes: Insights from genetic risk assessment”;Journal of Diabetes and its Complications;2024-08

3. Kidney transplantation: the recipient;Living Donor Organ Transplantation;2024

4. Genetic and epigenetic background of diabetic kidney disease;Frontiers in Endocrinology;2023-05-30

5. Screening and identification of key biomarkers in diabetic kidney disease and its complications: Evidence from bioinformatics and next generation sequencing data analysis;2023-04-18